Disclosures: Konopleva: Adaptive: Consultancy; Klondike Biopharma: Research Funding; Janssen: Consultancy, Other: clinical trials; Dark Blue Therapeutics: Membership on an entity's Board of Directors or advisory committees; Intellisphere: Speakers Bureau; MEI Pharma: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees; Curis: Consultancy; Auxenion GmbH: Membership on an entity's Board of Directors or advisory committees; Legend Biotech: Membership on an entity's Board of Directors or advisory committees; Menarini Group: Consultancy, Membership on an entity's Board of Directors or advisory committees; AbbVie: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: clinical trials, Research Funding; Vincerx: Consultancy; Sanofi Aventis: Consultancy; Syndax: Membership on an entity's Board of Directors or advisory committees; Servier: Speakers Bureau.